Peter Lebowitz
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
Dr. Peter F.
Lebowitz is an Independent Director at Bridgebio Oncology Therapeutics, Inc., an Independent Director at Bridgebio Oncology Therapeutics, Inc. /New/, a Chief Executive & Medical Officer, Director at Third Arc Bio, Inc. and a Head-Oncology Therapeutic Area at Janssen Research & Development LLC.
He is on the Board of Directors at Bridgebio Oncology Therapeutics, Inc., Bridgebio Oncology Therapeutics, Inc. /New/ and Third Arc Bio, Inc. Dr. Lebowitz was previously employed as a Chief Executive Officer by Aragon Pharmaceuticals, Inc.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
-.--% | 20/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Corporate Officer/Principal | - |
| Sociétés | Poste | Fin |
|---|---|---|
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 2 |
|---|---|
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national